Visit sirtoday.org for these stories and more
The consensus is in: SIR 2022 was worth waiting for. Workshops, lectures, didactic presentations and networking opportunities abounded as IRs from across the globe descended on Boston for a week of education and connection.
If you missed out on SIR 2022, you can purchase all recordings via SIR Now, and read the live coverage on SIR Today.
Dotter Lecture: An intentional philosophy
Mentorship is more than coaching. It’s an intentional philosophy—one that 2022 Dotter Lecturer Riad Salem, MD, MBA, FSIR, highly prioritizes. In his Dotter lecture, Dr. Salem focused on the many forms of mentorship and why it’s so impactful.
Dr. Salem shared his journey of mentorship, which started at age 14 during a summer French Literature course in Quebec. The student body was largely comprised of non-French speakers and, when he realized there was no translator, Dr. Salem stepped up to help. “For 6 weeks I was a mentor to hundreds of international students, some of whom were twice my age,” he said. “I learned something that summer. I enjoyed teaching and mentoring, and it came naturally to me. I knew it would be my future.” bit.ly/3O9IKop
Q&A with incoming SIR President Parag J. Patel, MD, FSIR
As Parag J. Patel, MD, FSIR, prepared to begin his term as SIR 2022–23 president, SIR Today talked with him about his goals, his passions, what inspires him and more. bit.ly/3b0vjJr
Celebrate the award winners of SIR 2022
SIR Today salutes the 2022 recipients of the most prestigious SIR and SIR Foundation awards with a personal look at their outstanding careers, asking them for a person, place and thing that has particularly inspired or influenced them.
Dotter Lecturer:
Riad Salem, MD, MBA, FSIR
SIR Gold Medalists:
- Janette D. Durham, MD, MBA, FSIR
- M. Victoria Marx, MD, FSIR
- Scott O. Trerotola, MD, FSIR
SIR Foundation Leaders in Innovation award: James B. Spies, MD, MPH, FSIR
Frederick S. Keller, MD, Philanthropy award: John JT Thomas, MD, FSIR
1 of 6
2 of 6
3 of 6
4 of 6
5 of 6
6 of 6
Paths to leadership for women in medicine
“Have you ever wondered why you never see speeches about paths to leadership for men?” asked Melina R. Kibbe, MD, FACS, FAHA, as she delivered the 2022 SIR Women in Interventional Radiology (WIR) Section InspIRed Lecture at the WIR Luncheon. The luncheon also featured 2022 WIR Champion Award recipient Kari J. Nelson, MD, FSIR. The impact of pain management SIR Today shares the story of a lifelong runner whose debilitating pain from chemotherapy put her dreams on hold— until she learned about cryoablation. bit.ly/3LW2Xwk
The six steps to reducing PAD
SIR has joined the mission to improve the awareness, diagnosis and treatment of peripheral arterial disease (PAD). Sanjay Misra, MD, FAHA, FSIR, presented the PAD National Action Plan, a multisociety collaborative effort with the American Heart Association that seeks to slow the spread of PAD and raise public awareness about the disease state.
Inside the award-winning science of SIR 2022 Featured abstracts:
New targeted ablation technique may improve immunotherapy in liver cancer
- Immunotherapy has been an exciting development to treat various cancers. Unfortunately, it is not that effective in patients with hepatocellular carcinoma (HCC) because of the high rates of cirrhosis. But a research team at the MD Anderson Cancer Center has developed a new technique that may improve the effectiveness of immunotherapy in HCC. bit.ly/3QnA7c2
AI model could diagnose liver cancer much earlier in cirrhosis patients
- Using an AI model that combines patient images and prognostic biomarker information could improve early diagnosis of hepatocellular carcinoma (HCC) among cirrhosis patients. bit.ly/3MR8CEy
Combination of chemo and TARE used to bridge liver cancer patients to surgery
- University of Chicago interventional radiologists collaborated with several specialties to combine treatment to improve the prognosis of patients with intrahepatic cholangiocarcinoma (iCCA). bit.ly/3txtVnZ
Sheep model can improve understanding of GAE
- Researchers successfully created a sheep model that mimics knee osteoarthritis in humans, which will allow IRs to better understand geniculate artery embolization (GAE). bit.ly/3QeRKux
Placenta accreta spectrum
- Intra-operative pelvic embolization may be more effective than internal iliac artery balloon occlusion (IIABO) at reducing blood loss for patients undergoing cesarean hysterectomy for placenta accreta spectrum, according to researchers. bit.ly/3QfgN0d
Radioembolization as first-line treatment for HCC leads to fewer treatments
- In a large retrospective multicenter Veterans Affairs (VA) trial, patients with hepatocellular carcinoma (HCC) initially treated with yttrium-90 (Y-90) radioembolization (TARE) underwent fewer subsequent therapies when compared with transarterial chemoembolization (TACE). bit.ly/3HbbJpH
Featured abstract: New treatment option for prostate cancer
- Transurethral ultrasound ablation is a promising treatment for prostate cancer, with better outcomes and fewer side effects than traditional treatment. bit.ly/3Qffw9r
Featured abstract: Registry demonstrates safe and effective removal of acute, subacute and chronic thrombus
- Recent outcomes from the ongoing, real-world CLOUT registry demonstrate that the ClotTriever System safely and effectively removes acute, subacute and chronic thrombus, according to data detailed in “Safety and effectiveness of the ClotTriever system for treating deep vein thrombosis of all chronicities: CLOUT registry six-month outcomes.” bit.ly/3QeIeaM
Featured abstract: Improving anti- HCC immune response
- Using a matrix metalloproteinase (MMP) inhibitor with cryoablation to treat hepatocellular carcinoma (HCC) improved CD8 T-cell immune response in a mice model, according to researchers. bit.ly/3MF23oG
Featured abstract preview: Height restoration
- Three different procedures were shown to demonstrate equivalent height restoration in patients with vertebral compression fractures, and one procedure in particular may exhibit less height loss in highly physical patients, according to a new study. bit.ly/3tn906Z
Featured abstract: AI as a predictor of TACE success
- A machine learning program at Penn State Heart and Vascular Institute was able to predict the response of hepatocellular carcinoma (HCC) to transarterial chemoembolization (TACE) in about 80% of the cases. However, the program performed even better when predicting long-term response. bit.ly/3awIsti
Abstracts of the year:
Y-90 radioembolization of colorectal cancer metastatic to the liver
- Yttrium-90 (Y-90) microsphere embolization, when deployedas part of second-line therapy, contributed to overall survivalin patients with colorectal liver metastases, according to data from the RESiN registry. bit.ly/3aS5Ph3
Y-90 as first-line treatment for intrahepatic cholangiocarcinoma
- Radioembolization can be considered as first-line treatment for unresectable intrahepatic cholangiocarcinoma (ICH). bit.ly/3zCdIl8
Potential new IR treatment for lumbar disc herniations
- Interventional radiologists may provide a more effective and minimally invasive treatment for lumbar disc herniations typically treated by open surgery, according to data from a recent European multicenter pilot trial. bit.ly/3NPG2EY
Breast cancer liver metastasis
- Physicians may be able to identify several new biomarkers related to immune activation to aid in patient selection for radioembolization of breast cancer liver metastasis, according to data in “Immune activation markers and response to radioembolization of breast cancer liver metastasis: Pilot study.” bit.ly/3O9dMgj
